Bifogade filer
ScandiDos and IBA Dosimetry deepen strategic alliance!
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
ScandiDos, a leading provider of state-of-the-art patient QA solutions in radiation therapy, announces a deeper partnership with IBA Dosimetry. Under a sales and interoperability agreement, the two companies enhance the workflow experience for radiation therapy clinics using the Delta4 Phantom+ measurement device and the IBA myQA iON software, benefiting both radiation therapy clinics and cancer patients worldwide.
This deepened partnership and agreement with IBA Dosimetry will not only reinforce ScandiDos´ position on the market but will also provide ScandiDos with an expected increase in sales of its flagship product Delta4 Phantom+. The intensification of the cooperation between the two companies will enable IBA to offer a new value-added solution to its customers. The partnership will benefit both radiation therapy clinics and cancer patients worldwide.
"We are thrilled to deepen our partnership with IBA Dosimetry, a company that shares our passion for advancing patient QA solutions” says Gustaf Piehl, CEO of ScandiDos. “The agreement with IBA is an important milestone for ScandiDos and underscores the value of our patient QA solutions in the industry."
The new sales and interoperability agreement between ScandiDos and IBA Dosimetry enables IBA to offer its customers a streamlined patient view where 3D measurements from the Delta4 Phantom+ can be displayed in the IBA myQA iON software. This feature gives IBA users a simple overview of the various calculations and measurements from both the Delta4 Phantom+ and IBA myQA iON software, saving time and improving accuracy.